Treatment of Unresecable and/or Metastatic Merkel Cell Carcinoma by Somatostatine Analogues

NCT02351128 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Merkel Cell

Interventions

DRUG: Lanreotide

Sponsor

University Hospital, Grenoble